Aiming to spare the neck: could smarter radiation cut side effects in oral cancer?

NCT ID NCT07121595

First seen Jul 31, 2026 ยท Last updated Jul 31, 2026

Summary

This phase II trial is testing whether a sentinel lymph node biopsy can guide radiation therapy to only one side of the neck in people with oral cavity squamous cell carcinoma. Currently, standard treatment often involves radiating both sides of the neck, which can harm saliva production, speech, and swallowing. By using the biopsy results to see if cancer has spread to lymph nodes, doctors hope to personalize radiation and spare the opposite side from unnecessary treatment. The study will measure how well this approach controls cancer recurrence in the neck and how it affects neck function and dryness.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Personalized radiation therapy directed by sentinel lymph node biopsy
What this could lead to
If successful, this approach could allow many patients with oral cavity cancer to receive radiation only on the side of the tumor, sparing the other side and reducing side effects like dry mouth and swallowing problems.
What could go wrong
This is a small pilot study, so results may not be definitive. There is a risk that skipping radiation to the opposite side could lead to a higher chance of cancer returning there, and the procedure itself carries standard risks of biopsy and radiation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ORAL CAVITY SQUAMOUS CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lip and oral cavity carcinoma Mouth Neoplasms oral cavity squamous cell carcinoma Squamous Cell Carcinoma of Head and Neck

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Michigan Comprehensive Cancer Center

    RECRUITING

    Ann Arbor, Michigan, 48109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.